Neuroinflammation with microglia activation is thought to be closely related to cortical multiple sclerosis (MS) lesion pathogenesis.
Objective:
Using 11C-PBR28 and 7 Tesla (7T) imaging, we assessed in 9 relapsing–remitting multiple sclerosis (RRMS) and 10 secondary progressive multiple sclerosis (SPMS) patients the following: (1) microglia activation in lesioned and normal-appearing cortex, (2) cortical lesion inflammatory profiles, and (3) the relationship between neuroinflammation and cortical integrity.
Methods:
Mean 11C-PBR28 uptake was measured in focal cortical lesions, cortical areas with 7T quantitative T2* (q-T2*) abnormalities, and normal-appearing cortex. The relative difference in cortical 11C-PBR28 uptake between patients and 14 controls was used to classify cortical lesions as either active or inactive. Disease burden was investigated according to cortical lesion inflammatory profiles. The relation between q-T2* and 11C-PBR28 uptake along the cortex was assessed.
Results:
11C-PBR28 uptake was abnormally high in cortical lesions in RRMS and SPMS; in SPMS, tracer uptake was significantly increased also in normal-appearing cortex. 11C-PBR28 uptake and q-T2* correlated positively in many cortical areas, negatively in some regions. Patients with high cortical lesion inflammation had worse clinical outcome and higher intracortical lesion burden than patients with low inflammation.
Conclusion:
11C-PBR28 and 7T imaging reveal distinct profiles of cortical inflammation in MS, which are related to disease burden.
PetersonJWBoLMorkS, et al. Transected neurites, apoptotic neurons, and reduced inflammation in cortical multiple sclerosis lesions. Ann Neurol2001; 50(3): 389–400.
2.
GeurtsJJCalabreseMFisherE, et al. Measurement and clinical effect of grey matter pathology in multiple sclerosis. Lancet Neurol2012; 11(12): 1082–1092.
3.
MagliozziRHowellOWReevesC, et al. A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis. Ann Neurol2010; 68(4): 477–493.
4.
MagliozziRHowellOWNicholasR, et al. Inflammatory intrathecal profiles and cortical damage in multiple sclerosis. Ann Neurol2018; 83(4): 739–755.
5.
BanatiRBNewcombeJGunnRN, et al. The peripheral benzodiazepine binding site in the brain in multiple sclerosis: Quantitative in vivo imaging of microglia as a measure of disease activity. Brain2000; 123(Pt. 11): 2321–2337.
6.
PolitisMGiannettiPSuP, et al. Increased PK11195 PET binding in the cortex of patients with MS correlates with disability. Neurology2012; 79(6): 523–530.
7.
HerranzEGianniCLouapreC, et al. Neuroinflammatory component of gray matter pathology in multiple sclerosis. Ann Neurol2016; 80(5): 776–790.
8.
FrischerJMWeigandSDGuoY, et al. Clinical and pathological insights into the dynamic nature of the white matter multiple sclerosis plaque. Ann Neurol2015; 78(5): 710–721.
9.
SethiVNairGAbsintaM, et al. Slowly eroding lesions in multiple sclerosis. Mult Scler2017; 23(3): 464–472.
10.
Dal-BiancoAGrabnerGKronnerwetterC, et al. Slow expansion of multiple sclerosis iron rim lesions: Pathology and 7 T magnetic resonance imaging. Acta Neuropathol2017; 133(1): 25–42.
11.
LassmannH.The pathologic substrate of magnetic resonance alterations in multiple sclerosis. Neuroimaging Clin N Am2008; 18(4): 563.ix–576.ix.
12.
KilsdonkIDJonkmanLEKlaverR, et al. Increased cortical grey matter lesion detection in multiple sclerosis with 7 T MRI: A post-mortem verification study. Brain2016; 139(Pt. 5): 1472–1481.
13.
LouapreCGovindarajanSTGianniC, et al. Beyond focal cortical lesions in MS: An in vivo quantitative and spatial imaging study at 7T. Neurology2015; 85(19): 1702–1709.
14.
OwenDRYeoAJGunnRN, et al. An 18-kDa translocator protein (TSPO) polymorphism explains differences in binding affinity of the PET radioligand PBR28. J Cereb Blood Flow Metab2012; 32(1): 1–5.
15.
ParmenterBATestaSMSchretlenDJ, et al. The utility of regression-based norms in interpreting the minimal assessment of cognitive function in multiple sclerosis (MACFIMS). J Int Neuropsychol Soc2010; 16(1): 6–16.
16.
KolbAWehrlHFHofmannM, et al. Technical performance evaluation of a human brain PET/MRI system. Eur Radiol2012; 22(8): 1776–1788.
17.
Van der KouweAJWBennerTSalatDH, et al. Brain morphometry with multiecho MPRAGE. Neuroimage2008; 40(2): 559–569.
18.
Izquierdo-GarciaDHansenAEForsterS, et al. An SPM8-based approach for attenuation correction combining segmentation and nonrigid template formation: Application to simultaneous PET/MR brain imaging. J Nucl Med2014; 55(11): 1825–1830.
19.
Cohen-AdadJPolimeniJRHelmerKG, et al. T2* mapping and B0 orientation-dependence at 7 T reveal cyto- and myeloarchitecture organization of the human cortex. Neuroimage2012; 60: 1006–1014.
20.
MaineroCLouapreCGovindarajanST, et al. A gradient in cortical pathology in multiple sclerosis by in vivo quantitative 7 T imaging. Brain2015; 138(Pt. 4): 932–945.
21.
HerranzEHookerJMIzquierdo-GarciaD, et al. Reply. Ann Neurol2017; 81(2): 324–325.
22.
StankoffBPoirionEToniettoM, et al. Exploring the heterogeneity of MS lesions using positron emission tomography: A reappraisal of their contribution to disability. Brain Pathol2018; 28(5): 723–734.
23.
KreislWCLyooCHLiowJS, et al. (11)C-PBR28 binding to translocator protein increases with progression of Alzheimer’s disease. Neurobiol Aging2016; 44: 53–61.
24.
AlshikhoMJZurcherNRLoggiaML, et al. Integrated magnetic resonance imaging and [(11) C]-PBR28 positron emission tomographic imaging in amyotrophic lateral sclerosis. Ann Neurol2018; 83(6): 1186–1197.
25.
ZrzavyTHametnerSWimmerI, et al. Loss of “homeostatic” microglia and patterns of their activation in active multiple sclerosis. Brain2017; 140(7): 1900–1913.
26.
LucchinettiCFPopescuBFBunyanRF, et al. Inflammatory cortical demyelination in early multiple sclerosis. N Engl J Med2011; 365(23): 2188–2197.
27.
KutzelniggALucchinettiCFStadelmannC, et al. Cortical demyelination and diffuse white matter injury in multiple sclerosis. Brain2005; 128(Pt. 11): 2705–2712.
28.
BevanRJEvansRGriffithsL, et al. Meningeal inflammation and cortical demyelination in acute multiple sclerosis. Ann Neurol2018; 84(6): 829–842.
29.
RissanenETuiskuJRokkaJ, et al. In vivo detection of diffuse inflammation in secondary progressive multiple sclerosis using PET imaging and the radioligand 11C-PK11195. J Nucl Med2014; 55(6): 939–944.
30.
GreveDNSvarerCFisherPM, et al. Cortical surface-based analysis reduces bias and variance in kinetic modeling of brain PET data. Neuroimage2014; 92: 225–236.
31.
HamelinLLagardeJDorotheeG, et al. Distinct dynamic profiles of microglial activation are associated with progression of Alzheimer’s disease. Brain2018; 141(6): 1855–1870.
32.
StaugaitisSMChangATrappBD.Cortical pathology in multiple sclerosis: Experimental approaches to studies on the mechanisms of demyelination and remyelination. Acta Neurol Scand Suppl2012; 195; 97–102.
33.
MangeatGGovindarajanSTMaineroC, et al. Multivariate combination of magnetization transfer, T2* and B0 orientation to study the myelo-architecture of the in vivo human cortex. Neuroimage2015; 119: 89–102.
34.
LavisseSGuillermierMHerardAS, et al. Reactive astrocytes overexpress TSPO and are detected by TSPO positron emission tomography imaging. J Neurosci2012; 32(32): 10809–10818.
35.
MallucciGPeruzzotti-JamettiLBernstockJD, et al. The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis. Prog Neurobiol2015; 127–128: 1–22.
